^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    cabotamig (ARB202)

    i
    Other names: ARB202
    Associations

    News

    Trials
    Company:
    Arbele
    Drug class:
    CD3 agonist, CDH17 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over2years
    Treatment of ARB202 Advanced Gastrointestinal Cancer Patients (clinicaltrials.gov)
    P1, N=68, Recruiting, Arbele Pty Ltd
    New P1 trial
    |
    IL2 (Interleukin 2)
    |
    CDH1 expression
    |
    Tecentriq (atezolizumab) • cabotamig (ARB202)